Literature DB >> 25649157

Ocular features in Alport syndrome: pathogenesis and clinical significance.

Judy Savige1, Shivanand Sheth2, Anita Leys3, Anjali Nicholson4, Heather G Mack5, Deb Colville6.   

Abstract

Alport syndrome is an inherited disease characterized by progressive renal failure, hearing loss, and ocular abnormalities. Mutations in the COL4A5 (X-linked), or COL4A3 and COL4A4 (autosomal recessive) genes result in absence of the collagen IV α3α4α5 network from the basement membranes of the cornea, lens capsule, and retina and are associated with corneal opacities, anterior lenticonus, fleck retinopathy, and temporal retinal thinning. Typically, these features do not affect vision or, in the case of lenticonus, are correctable. In contrast, the rarer ophthalmic complications of posterior polymorphous corneal dystrophy, giant macular hole, and maculopathy all produce visual loss. Many of the ocular features of Alport syndrome are common, easily recognizable, and thus, helpful diagnostically, and in identifying the likelihood of early-onset renal failure. Lenticonus and central fleck retinopathy strongly suggest the diagnosis of Alport syndrome and are associated with renal failure before the age of 30 years, in males with X-linked disease. Sometimes, ophthalmic features suggest the mode of inheritance. A peripheral retinopathy in the mother of a male with hematuria suggests X-linked inheritance, and central retinopathy or lenticonus in a female means that recessive disease is likely. Ocular examination, retinal photography, and optical coherence tomography are widely available, safe, fast, inexpensive, and acceptable to patients. Ocular examination is particularly helpful in the diagnosis of Alport syndrome when genetic testing is not readily available or the results are inconclusive. It also detects complications, such as macular hole, for which new treatments are emerging.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  Alport syndrome; extracellular matrix; genetic renal disease

Mesh:

Substances:

Year:  2015        PMID: 25649157      PMCID: PMC4386265          DOI: 10.2215/CJN.10581014

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  62 in total

1.  Symmetrical reduced retinal thickness in a patient with Alport syndrome.

Authors:  Tomoaki Usui; Mikio Ichibe; Shigeru Hasegawa; Atsushi Miki; Eriko Baba; Naoyuki Tanimoto; Haruki Abe
Journal:  Retina       Date:  2004-12       Impact factor: 4.256

Review 2.  The alpha chains of type IV collagen.

Authors:  J Zhou; S T Reeders
Journal:  Contrib Nephrol       Date:  1996       Impact factor: 1.580

3.  Glomerular basement membrane. Identification of a novel disulfide-cross-linked network of alpha3, alpha4, and alpha5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome.

Authors:  S Gunwar; F Ballester; M E Noelken; Y Sado; Y Ninomiya; B G Hudson
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

4.  Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis.

Authors:  R Kalluri; C F Shield; P Todd; B G Hudson; E G Neilson
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

5.  Recurrent corneal erosion associated with Alport's syndrome. Rapid communication.

Authors:  C Rhys; B Snyers; Y Pirson
Journal:  Kidney Int       Date:  1997-07       Impact factor: 10.612

6.  Anterior lens capsule abnormalities in Alport syndrome.

Authors:  Jae hyuk Choi; Kyung sool Na; Seon hee Bae; Gyoung hwan Roh
Journal:  Korean J Ophthalmol       Date:  2005-03

7.  An ultrastructural investigation of an early manifestation of the posterior polymorphous dystrophy of the cornea.

Authors:  W Sekundo; W R Lee; C M Kirkness; D A Aitken; B Fleck
Journal:  Ophthalmology       Date:  1994-08       Impact factor: 12.079

Review 8.  Alport syndrome. A review of the ocular manifestations.

Authors:  D J Colville; J Savige
Journal:  Ophthalmic Genet       Date:  1997-12       Impact factor: 1.803

9.  Alport's syndrome with bilateral macular hole.

Authors:  U O Mete; C Karaaslan; M K Ozbilgin; S Polat; O Tap; M Kaya
Journal:  Acta Ophthalmol Scand       Date:  1996-02

10.  Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome.

Authors:  T Mochizuki; H H Lemmink; M Mariyama; C Antignac; M C Gubler; Y Pirson; C Verellen-Dumoulin; B Chan; C H Schröder; H J Smeets
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

View more
  42 in total

Review 1.  Tissue linkage through adjoining basement membranes: The long and the short term of it.

Authors:  Daniel P Keeley; David R Sherwood
Journal:  Matrix Biol       Date:  2018-05-24       Impact factor: 11.583

2.  Simultaneous Bilateral Anterior and Posterior Lenticonus in Alport Syndrome.

Authors:  Ravi Kant Bamotra; Prem Chandra Kesarwani; Shazia Qayum
Journal:  J Clin Diagn Res       Date:  2017-08-01

3.  Renal, auricular, and ocular outcomes of Alport syndrome and their current management.

Authors:  Yanqin Zhang; Jie Ding
Journal:  Pediatr Nephrol       Date:  2017-09-01       Impact factor: 3.714

4.  Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits.

Authors:  Wen Ding; Keyvan Yousefi; Stefania Goncalves; Bradley J Goldstein; Alfonso L Sabater; Amy Kloosterboer; Portia Ritter; Guerline Lambert; Armando J Mendez; Lina A Shehadeh
Journal:  JCI Insight       Date:  2018-03-22

5.  Alport Syndrome in Women and Girls.

Authors:  Judy Savige; Deb Colville; Michelle Rheault; Susie Gear; Rachel Lennon; Sharon Lagas; Moira Finlay; Frances Flinter
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-10       Impact factor: 8.237

6.  Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family.

Authors:  Liwei Guo; Duan Li; Shuangshuang Dong; Donghao Wan; Baosheng Yang; Yanmei Huang
Journal:  J Genet       Date:  2017-06       Impact factor: 1.166

7.  [Analysis of Alport syndrome induced by type IV collagen alpha 5 gene mutation in two families].

Authors:  Qing Ye; Yingying Zhang; Jingjing Wang; Jianhua Mao
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-06-25

8.  Soluble Urokinase Receptor Levels in Secondary Focal Segmental Glomerulosclerosis.

Authors:  Pingping Sun; Lei Yu; Jing Huang; Suxia Wang; Wanzhong Zou; Li Yang; Gang Liu
Journal:  Kidney Dis (Basel)       Date:  2019-05-27

9.  The use of pan-retinal photocoagulation to treat recurrent vitreous haemorrhage with neovascularisation in the context of Epstein syndrome: an MYH9-related disorder.

Authors:  Francis William Barwise Sanders; Emma Thompson; Harry Roberts; Nitin Gupta
Journal:  BMJ Case Rep       Date:  2019-12-29

Review 10.  Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020.

Authors:  Clifford E Kashtan; Oliver Gross
Journal:  Pediatr Nephrol       Date:  2020-11-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.